GI
IMNM icon

GAMMA Investing’s Immunome IMNM Stock Holding History

GAMMA Investing’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$46.5K Buy
2,164
+484
+29% +$12K ﹤0.01% 2416
2026
Q2 		$35.6K Buy
1,680
+90
+6% +$1.93K ﹤0.01% 2529
2026
Q1 		$34.8K Buy
1,590
+211
+15% +$4.7K ﹤0.01% 2424
2025
Q4 		$29.6K Buy
1,379
+441
+47% +$7.74K ﹤0.01% 2397
2025
Q3 		$11K Buy
938
+7
+0.8% +$70 ﹤0.01% 2835
2025
Q2 		$8.66K Buy
931
+19
+2% +$156 ﹤0.01% 2875
2025
Q1 		$6.14K Buy
912
+702
+334% +$6.74K ﹤0.01% 2995
2024
Q4 		$2.23K Buy
210
+81
+63% +$979 ﹤0.01% 3191
2024
Q3 		$1.89K Buy
+129
New +$1.83K ﹤0.01% 3089

Other funds holding IMNM

MWM
Maltin Wealth Management Ridgewood, New Jersey $308M AUM 16.5% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's IMNM Position: Q3 2026 in Review

GAMMA Investing increased its Immunome (IMNM) stake by 29% in Q3 2026, buying an estimated $12K and bringing the position to 2,164 shares worth $46.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2416.

GAMMA Investing first reported a position in IMNM in Q3 2024 and has held it in 9 quarters since. 6 funds tracked by Wall St. Rank hold IMNM as of Q3 2026.

  • GAMMA Investing held 2,164 shares of Immunome worth $46.5K as of Q3 2026.
  • GAMMA Investing bought 484 Immunome shares in Q3 2026, an estimated $12K.
  • Immunome made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2416 holding.
  • GAMMA Investing first reported a position in Immunome in Q3 2024 and has held it in 9 quarters since.
  • 6 funds tracked by Wall St. Rank held Immunome as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.